Epidemiological investigations of an outbreak of intestinal atresia in two Israeli dairy herds

An epidemiological investigation of an outbreak of intestinal atresia in Israeli Holstein-Friesian newborn calves showed a linkage with rectal palpation for early pregnancy diagnosis, performed less than 42 days after insemination. The odds of an exposed calf, i.e., one born to a dam that was diagnosed by early palpation as having intestinal atresia were 119.7 times higher than one born in normal control herds (95% CI; 7.4-1946.3). A total of 682 calves-at-risk was recorded from mid-1998 to mid-2000 and a total of 47 calves (6.9%) were born with intestinal atresia during this period. Two forms of intestinal atresia were recognized at post-mortem: atresia coli and atresia ilei.     

Congenital thymic aplasia in a Holstein-Israeli female calf

An unusual case of congenital thymic aplasia in a Holstein-Israeli female calf is described. The most prominent clinical findings were diarrhoea and weakness. At necropsy, the only significant pathological finding was the marked decrease in thymus size. Histologically, this organ was composed of loose connective tissue in which a few lymphocytes were scattered randomly.     

Case report: primary fibrosarcoma of the liver in a cow.

An unusual case of primary fibrosarcoma of the liver in a cow is described. The most prominent pathological findings were severe abdominal haemorrhage and neoplastic masses confined to the liver only. Histologically, spindeloid cells arranged in interlacing bundles running in various directions and numerous areas of necrosis and ossification were randomly scattered in the neoplasm.     

Congenital Thymic Aplasia in a Holstein‐Israeli female Calf

An unusual case of congenital thymic aplasia in a Holstein‐Israeli female calf is described. The most prominent clinical findings were diarrhoea and weakness. At necropsy, the only significant pathological finding was the marked decrease in thymus size. Histologically, this organ was composed of loose connective tissue in which a few lymphocytes were scattered randomly.     

Safety and efficacy of sFilm-FS,a novel biodegradable fibrin sealant,in Göttingen minipigs

Bleeding during surgical procedures is a common complication. Therefore, hemostatic agents have been developed to control bleeding, and fibrin sealants have several benefits. sFilm-FS is a novel fibrin sealant that comprises a biodegradable co-polymeric film embedded with human fibrinogen and thrombin. Herein, the safety and efficacy of sFilm-FS were compared using a liver and spleen puncture model of Göttingen minipigs with those of the standard hemostatic techniques (control animals) and EVARREST^®, a reference fibrin sealant. Hemostasis and reduced blood loss were more effectively achieved with sFilm-FS than with the standard techniques in the control animals and comparable to those achieved with EVARREST^®. No treatment-related adverse effects were observed in any of the groups. Histopathological evaluation indicated that sFilm-FS was slightly and moderately reactive at the liver puncture site and spleen, respectively, compared with the standard techniques in the control animals. These changes are expected degradation reactions of the co-polymeric film and are not considered as adverse events. No treatment-related abnormalities were noted in the other evaluated organs. Additionally, no evidence of local or systemic thromboses was noted. These results support the use of sFilm-FS for hemostasis in humans.